329 related articles for article (PubMed ID: 19068252)
21. Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats.
Li Y; Vijayanathan V; Gulinello ME; Cole PD
Pharmacol Biochem Behav; 2010 Jan; 94(3):454-63. PubMed ID: 19887080
[TBL] [Abstract][Full Text] [Related]
22. Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter.
Laxmi SN; Takahashi S; Matsumoto K; Higano S; Kurihara N; Imaizumi M; Abe K; Itoyama Y; Sakamoto K
Radiat Med; 1996; 14(6):303-7. PubMed ID: 9132810
[TBL] [Abstract][Full Text] [Related]
23. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
Vlacha V; Eliopoulou M; Haidas S; Beratis NG
Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
[TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid lactic dehydrogenase activity in children with acute lymphoblastic leukemia treated for cranial prophylaxis.
Caglar MK; Hicsonmez G; Renda N
Paediatr Indones; 1989; 29(5-6):112-5. PubMed ID: 2812823
[TBL] [Abstract][Full Text] [Related]
25. Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia.
Van Gool SW; De Meyer G; Van de Voorde A; Vanmechelen E; Vanderstichele H
Neurotoxicology; 2004 Mar; 25(3):471-80. PubMed ID: 15019310
[TBL] [Abstract][Full Text] [Related]
26. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia.
Aytaç S; Yetgin S; Tavil B
Turk J Pediatr; 2006; 48(1):1-7. PubMed ID: 16562778
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of the detection of the sL-selectin level in patients with acute leukemia].
Chang JH; Qi ZH; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):151-3. PubMed ID: 12575346
[TBL] [Abstract][Full Text] [Related]
28. Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy.
Peng CT; Wu KH; Lan SJ; Tsai JJ; Tsai FJ; Tsai CH
Eur J Cancer; 2005 May; 41(8):1158-63. PubMed ID: 15911239
[TBL] [Abstract][Full Text] [Related]
29. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors.
Duffner PK
Neurologist; 2004 Nov; 10(6):293-310. PubMed ID: 15518596
[TBL] [Abstract][Full Text] [Related]
30. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
[TBL] [Abstract][Full Text] [Related]
31. Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia.
Miketova P; Kaemingk K; Hockenberry M; Pasvogel A; Hutter J; Krull K; Moore IM
Biol Res Nurs; 2005 Jan; 6(3):187-95. PubMed ID: 15583359
[TBL] [Abstract][Full Text] [Related]
32. Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist.
Vijayanathan V; Gulinello M; Ali N; Cole PD
Behav Brain Res; 2011 Dec; 225(2):491-7. PubMed ID: 21856332
[TBL] [Abstract][Full Text] [Related]
33. Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only.
Kingma A; van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
J Pediatr; 2001 Sep; 139(3):413-20. PubMed ID: 11562622
[TBL] [Abstract][Full Text] [Related]
34. [Complications in the central nervous system during chemotherapy for childhood acute lymphoblastic leukemia: JACLS ALL-02 study].
Umeda K; Yoshida M; Suzuki N; Endo M; Sato A; Hori H; Isogai M; Matsumoto K; Hara JI; Hasegawa D; Hashii Y; Chayama K; Miyaji R; Nishimura S; Tanizawa A; Uami I; Horibe K; Wakazono Y; Yagi K
Rinsho Ketsueki; 2007 Mar; 48(3):204-11. PubMed ID: 17441477
[TBL] [Abstract][Full Text] [Related]
35. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
Eisenkraft A; Keidan I; Bielorai B; Keller N; Toren A; Paret G
Leuk Res; 2006 Oct; 30(10):1259-61. PubMed ID: 16516290
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy.
Cole PD; Zebala JA; Alcaraz MJ; Smith AK; Tan J; Kamen BA
Cancer Chemother Pharmacol; 2006 Jun; 57(6):826-34. PubMed ID: 16170572
[TBL] [Abstract][Full Text] [Related]
37. Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia.
Nakagawa K
Cell Mol Biol (Noisy-le-grand); 2000 Dec; 46(8):1375-81. PubMed ID: 11156482
[TBL] [Abstract][Full Text] [Related]
38. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia.
Halonen P; Salo MK; Mäkipernaa A
J Pediatr; 2001 Mar; 138(3):428-31. PubMed ID: 11241057
[TBL] [Abstract][Full Text] [Related]
39. [Study of lactate dehydrogenase isoenzyme in the cerebrospinal fluid of patients with acute lymphoblastic leukemia].
Lesnichenko IF; Gubarenko NK; Gritsaev SV; Salmykova NB; Blinov MN
Vopr Onkol; 2008; 54(1):59-61. PubMed ID: 18416059
[TBL] [Abstract][Full Text] [Related]
40. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
